Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luanbiao Sun

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Biochemical Pharmacology|June 27, 2025
Puerarin as a dual inhibitor of Staphylococcus aureus coagulase and von Willebrand factor-binding protein for targeted therapy against MRSA skin infectionZhangyu Du, Yun Sun, Yifei Shan, et al.
Biochemical Pharmacology|December 17, 2025
Saikosaponin D from Bupleurum targets SaeR to disrupt biofilm formation and pathogenic programs for the treatment of MRSA pneumoniaShidong Zhang, Yanhe Luan, Li Wang, et al.
World Journal of Microbiology & Biotechnology|March 30, 2026
Daphnoretin as a potent sortase A inhibitor effectively disarms drug-resistant Staphylococcus aureus infectionsYun Sun, Tong Zhao, Dongbin Guo, et al.
NPJ Biofilms and Microbiomes|March 19, 2025
Baohuoside I targets SaeR as an antivirulence strategy to disrupt MRSA biofilm formation and pathogenicityYueshan Xu, Li Wang, Dongbin Guo, et al.
Journal of Nanobiotechnology|March 22, 2026
Tetrahedral framework nucleic acid delivery of emodin enables precision antibacterial and anti-inflammatory therapy for drug-resistant Staphylococcus aureusPeitong Jiang, Li Wang, Yun Sun, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Biochemical Pharmacology|June 27, 2025
Puerarin as a dual inhibitor of Staphylococcus aureus coagulase and von Willebrand factor-binding protein for targeted therapy against MRSA skin infectionZhangyu Du, Yun Sun, Yifei Shan, et al.
Biochemical Pharmacology|December 17, 2025
Saikosaponin D from Bupleurum targets SaeR to disrupt biofilm formation and pathogenic programs for the treatment of MRSA pneumoniaShidong Zhang, Yanhe Luan, Li Wang, et al.
World Journal of Microbiology & Biotechnology|March 30, 2026
Daphnoretin as a potent sortase A inhibitor effectively disarms drug-resistant Staphylococcus aureus infectionsYun Sun, Tong Zhao, Dongbin Guo, et al.
NPJ Biofilms and Microbiomes|March 19, 2025
Baohuoside I targets SaeR as an antivirulence strategy to disrupt MRSA biofilm formation and pathogenicityYueshan Xu, Li Wang, Dongbin Guo, et al.
Journal of Nanobiotechnology|March 22, 2026
Tetrahedral framework nucleic acid delivery of emodin enables precision antibacterial and anti-inflammatory therapy for drug-resistant Staphylococcus aureusPeitong Jiang, Li Wang, Yun Sun, et al.
Pageof 2